Revvity | PKI - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Agilent USD 364M 78M 2025-12
Align Technology USD 148.89M 27.71M 2026-03
Bio Techne USD 50.78M 34.21M 2025-12
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Bruker USD 68.2M 140.8M 2025-12
Celltrion KRW 10.5B 4.1B 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Danaher USD 1.24B 138M 2026-03
Dentsply International USD -42M 105M 2026-03
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 9.63B 1.09B 2026-03
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Illumina USD 157M 220M 2026-03
Intuitive Surgical USD 955.6M 100.4M 2025-12
IQVIA Holdings USD 6.22B 5.68B 2026-03
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Laboratory Of America USD 8.73B 8.54B 2026-03
Medical Developments International AUD -149K 466K 2025-06
Mesa Laboratories USD -2.22M 6.03M 2024-12
Mettler Toledo International USD 329.07M 59.84M 2025-12
Myriad Genetics USD 4.6M 3.4M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
OraSure Technologies USD -18.43M 5.14M 2025-12
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Pharma Mar EUR 1.6M 38.6M 2026-03
Qiagen NV USD 109.17M 25.56M 2025-12
Quest Diagnostics USD 334M 4M 2026-03
Quidel USD -79.5M 32.9M 2026-03
Repligen USD 19.11M 2M 2025-12
Revvity USD 91.56M 35.88M 2025-12
Sartorius EUR 157.8M 76.1M 2026-03
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tilray USD -39.96M 39.19M 2025-09
Waters USD 264.18M 94.06M 2025-12
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03